ArticleFrontiers in psychiatry2025
Effects of positive psychological interventions on quality of life in patients with first-episode depression.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to investigate the effects of positive psychological interventions (PPIs) on improving the quality of life in first-episode depression patients. Methods: A total of 200 first-episode depression patients were randomly assigned to a control group (n=100, conventional nursing) or a study group (n=100, conventional care plus four weekly 60-80-minute PPI sessions over one month). Depression severity (Hamilton Depression Rating Scale, HAMD), psychological resilience (Connor-Davidson Resilience Scale, CD-RISC), self-acceptance (Self Acceptance Questionnaire, SAQ), and quality of life (SF-36) were assessed pre-intervention and 3 months post-intervention. Results: Baseline measures showed no significant intergroup differences (P>0.05). At 3 months, the study group exhibited greater HAMD reduction (Δ=11.16 vs. Δ=9.09 in controls; mean post-intervention: 17.03 ± 3.45 vs. 19.23 ± 3.21, p<0.001), higher CD-RISC improvement (Δ=36.27 vs. Δ=29.54; 80.09 ± 7.86 vs. 73.92 ± 7.36, p<0.001), and increased SAQ total scores (Δ=18.17 vs. Δ=12.25; 43.47 ± 9.21 vs. 37.84 ± 8.24, p<0.001). SF-36 total scores improved by 52.0% in the study group (540.41 ± 32.66 vs. 276.41 ± 27.99) compared to 42.5% in controls (487.85 ± 31.89 vs. 279.48 ± 26.39, p<0.001). Conclusion: PPIs delivered over four weeks significantly enhance quality of life and psychological outcomes in first-episode depression, supporting clinical adoption.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.